These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36649782)

  • 1. Long-Term Follow-up of Graves Orbitopathy After Treatment With Short- or Long-Term Methimazole or Radioactive Iodine.
    Azizi F; Abdi H; Mehran L; Perros P; Masoumi S; Amouzegar A
    Endocr Pract; 2023 Apr; 29(4):240-246. PubMed ID: 36649782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of post-radioactive iodine relapse of hyperthyroidism: comparison of long-term methimazole and radioactive iodine treatment.
    Saadat N; Azizi F; Abdi H; Amouzegar A
    J Endocrinol Invest; 2022 Oct; 45(10):1919-1924. PubMed ID: 35610532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioiodine therapy versus antithyroid medications for Graves' disease.
    Ma C; Xie J; Wang H; Li J; Chen S
    Cochrane Database Syst Rev; 2016 Feb; 2(2):CD010094. PubMed ID: 26891370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in graves' ophthalmopathy after radioiodine and anti-thyroid drug treatment of Graves' disease from 2 prospective, randomized, open-label, blinded end point studies.
    Chen DY; Schneider PF; Zhang XS; Luo XY; He ZM; Chen TH
    Exp Clin Endocrinol Diabetes; 2014 Jan; 122(1):1-6. PubMed ID: 24203649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of patients with hyperthyroidism due to Graves' disease treated with methimazole. Comparison of usual treatment schedule with drug discontinuation vs continuous treatment with low methimazole doses: a retrospective study.
    Mazza E; Carlini M; Flecchia D; Blatto A; Zuccarini O; Gamba S; Beninati S; Messina M
    J Endocrinol Invest; 2008 Oct; 31(10):866-72. PubMed ID: 19092290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to Normalization and Sustainable Normal Serum Thyrotropin Concentrations in Patients with Hyperthyroidism: Comparison of Methimazole and Radioactive Iodine Treatments.
    Azizi F; Saadat N; Abdi H; Mehran L; Masoumi S; Takyar MA; Amouzegar A
    Endocr Pract; 2022 Nov; 28(11):1140-1145. PubMed ID: 35948251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes in Relapsed Graves' Disease Patients Following Radioiodine or Prolonged Low Dose of Methimazole Treatment.
    Villagelin D; Romaldini JH; Santos RB; Milkos AB; Ward LS
    Thyroid; 2015 Dec; 25(12):1282-90. PubMed ID: 26414885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study.
    De Bellis A; Conzo G; Cennamo G; Pane E; Bellastella G; Colella C; Iacovo AD; Paglionico VA; Sinisi AA; Wall JR; Bizzarro A; Bellastella A
    Endocrine; 2012 Apr; 41(2):320-6. PubMed ID: 22169963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence of ophthalmopathy after radioiodine therapy for Graves' disease: prognostic factors and the role of methimazole.
    Kung AW; Yau CC; Cheng A
    J Clin Endocrinol Metab; 1994 Aug; 79(2):542-6. PubMed ID: 7913934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Risk of Radioiodine Treatment Failure Associated with Graves Disease Refractory to Methimazole.
    Kwak JJ; Altoos R; Jensen A; Altoos B; McDermott MT
    Endocr Pract; 2020 Nov; 26(11):1312-1319. PubMed ID: 33471662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Graves Thyroidal and Extrathyroidal Disease: An Update.
    Kahaly GJ
    J Clin Endocrinol Metab; 2020 Dec; 105(12):3704-20. PubMed ID: 32929476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
    N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of Graves' hyperthyroidism with very long-term methimazole treatment: a clinical trial.
    Azizi F; Abdi H; Amouzegar A
    BMC Endocr Disord; 2021 Jan; 21(1):16. PubMed ID: 33446181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful Re-administration of Low-dose of Methimazole (MMI) in Graves' Disease Patients Who Experienced Allergic Cutaneous Reactions to MMI at Initial Treatment and Had Received Long-term Propylthiouracil (PTU).
    Kubota S
    Intern Med; 2016; 55(22):3235-3237. PubMed ID: 27853063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid-associated ophthalmopathy; quality of life follow-up of patients randomized to treatment with antithyroid drugs or radioiodine.
    Abraham-Nordling M; Wallin G; Träisk F; Berg G; Calissendorff J; Hallengren B; Hedner P; Lantz M; Nyström E; Asman P; Lundell G; Törring O;
    Eur J Endocrinol; 2010 Oct; 163(4):651-7. PubMed ID: 20660002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothyroidism during antithyroid drug treatment with methimazole is a favorable prognostic indicator in patients with Graves' disease.
    Choo YK; Yoo WS; Kim DW; Chung HK
    Thyroid; 2010 Sep; 20(9):949-54. PubMed ID: 20629556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Long-Term Methimazole versus Radioactive Iodine in the Treatment of Toxic Multinodular Goiter.
    Azizi F; Saadat N; Takyar MA; Abdi H; Mehran L; Amouzegar A
    Endocrinol Metab (Seoul); 2022 Dec; 37(6):861-869. PubMed ID: 36415961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and treatment of Graves disease.
    Streetman DD; Khanderia U
    Ann Pharmacother; 2003; 37(7-8):1100-9. PubMed ID: 12841824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Subclinical Hyperthyroidism in the Elderly: Comparison of Radioiodine and Long-Term Methimazole Treatment.
    Azizi F; Abdi H; Cheraghi L; Amouzegar A
    Thyroid; 2021 Apr; 31(4):545-551. PubMed ID: 32811342
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcome of pediatric Graves' disease after treatment with antithyroid medication and radioiodine.
    Ward L; Huot C; Lambert R; Deal C; Collu R; Van Vliet G
    Clin Invest Med; 1999 Aug; 22(4):132-9. PubMed ID: 10497711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.